HomeAI · summaries
Storia in 3 fonti
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
Experts explain why semaglutide and other weight-loss drugs may not work for everyone
Weight-loss jabs are the latest craze for shedding a few pounds
- ·
cnbc.com
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
